Bioverse NAD+ prices
2 figures read September 2026.
Every NAD+ figure Bioverse publishes is a floor — a “from” or “starting at” price, $259 at the bottom — so the number on the page is where its range begins and not necessarily a price anyone is charged.
What Bioverse publishes
Bioverse publishes only a floor — a “from” or “starting at” figure, which is the bottom of a range and not a price anyone is necessarily charged. Of the 29 sellers in this index that fall in the same bucket, that puts it with the 27% of the roster that publishes this shape of number rather than another one. A standing rate charged on a calendar month is the only figure this site treats as a monthly price, and 60 of the 106 sellers in this index — including this one — do not publish one.
The figure above is a from-price, “/mo”. This site never prints a price without that qualifier, on any surface, because the same number means a different thing depending on it — and in this corpus the same seller often prints several.
Every figure Bioverse publishes — 2 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $339 | unresolved | no cycle stated | SubQ | Not stated | September 2026 |
| $259 | from-price | “/mo” | SubQ | Not stated | September 2026 |
In Bioverse’s own words
- $339 unresolved
The page says: “Starting at $339”
Not resolved. First of an unlabelled two-number pair rendered as 'Starting at $339 $259/mo'. The capture stores textContent so a <del> is invisible; the page never says which figure is current. The seller's later sentence settles the LOWER number only.
Rendered adjacent to $259/mo with neither labelled; recorded as a separate offer per the two-unlabelled-numbers rule. Dosage is provider-set: 'If appropriate, a provider will prescribe a dosage based on your health history and goals.'
Read from https://www.gobioverse.com/product/nad-injection on September 2026.
- $259 from-price
The page says: “Starting at $339 $259/mo”
Second of the two unlabelled hero figures. Restated later on the same page as 'Starts at $259/month. Lower than 12 leading brands.*' - one price, two statements, not two offers.
Read from https://www.gobioverse.com/product/nad-injection on September 2026.
Price disclosure score: 61 of 100
This scores what Bioverse publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. Bioverse sits 75 of 106.
| What is scored | What Bioverse publishes | Points |
|---|---|---|
| An exact figure | The published figure is a floor — a “from” or “starting at” number, which is the bottom of a range and not necessarily a price anyone is charged. | 6of 30 |
| A stated cadence | The seller states the interval it bills on, so a reader knows when the next charge lands. | 20of 20 |
| Visible on the page | Every headline figure (1 figure) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | None of this seller's 2 figures states a dose, so no cost per milligram can be worked out from the page. | 0of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 61of 100 |
What Bioverse does not publish
Each of these is a count over what was actually read, not an impression. 2 figures were read from this seller, and every sentence below is measured against that number.
- None of the 2 figures read from this seller is a standing rate charged by the calendar month.
- No dose is stated beside any of the 2 figures, so nothing on the page divides into a cost per milligram.
- 1 of 2 figures could not be resolved into a price at all. Each carries the reason on this page, and none of them is estimated, averaged or guessed at.
Figures visible to a reader on the seller’s page
2 of 2
Figures stating a dose
0 of 2
Figures that resolve to a usable price
1 of 2
Source: Counted over the 2 figures read from Bioverse’s own pages, September 2026. Each track is that figure count.
Where Bioverse sits
60 other sellers in this index also state a SubQ route. Ranked with them on price disclosure, Bioverse is 45 of 61. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards Bioverse appears on
The reading record
This site has read Bioverse once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from Bioverse’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.